233 related articles for article (PubMed ID: 23674848)
1. Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors.
Liu LC; Xu WT; Wu X; Zhao P; Lv YL; Chen L
World J Gastroenterol; 2013 Apr; 19(16):2473-80. PubMed ID: 23674848
[TBL] [Abstract][Full Text] [Related]
2. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
[TBL] [Abstract][Full Text] [Related]
3. CD133 and Ki-67 expression is associated with gastrointestinal stromal tumor prognosis.
Lu C; Liu L; Wu X; Xu W
Oncol Lett; 2013 Nov; 6(5):1289-1294. PubMed ID: 24179510
[TBL] [Abstract][Full Text] [Related]
4. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
Wang Y; Chen JJ; Wang XF; Wang Q
World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors.
Jiang J; Jin MS; Suo J; Wang YP; He L; Cao XY
World J Gastroenterol; 2012 May; 18(20):2569-75. PubMed ID: 22654456
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway.
Steigen SE; Bjerkehagen B; Haugland HK; Nordrum IS; Løberg EM; Isaksen V; Eide TJ; Nielsen TO
Mod Pathol; 2008 Jan; 21(1):46-53. PubMed ID: 17917670
[TBL] [Abstract][Full Text] [Related]
8. Clinico-pathological characteristics and prognostic factors of gastrointestinal stromal tumors among a Chinese population.
Li J; Zhang H; Chen Z; Su K
Int J Clin Exp Pathol; 2015; 8(12):15969-76. PubMed ID: 26884871
[TBL] [Abstract][Full Text] [Related]
9. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.
Miettinen M; Felisiak-Golabek A; Wang Z; Inaguma S; Lasota J
Am J Surg Pathol; 2017 May; 41(5):577-585. PubMed ID: 28288036
[TBL] [Abstract][Full Text] [Related]
10. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
Basilio-de-Oliveira RP; Pannain VL
World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance of Ki-67 expression in patients undergoing surgical resection for gastrointestinal stromal tumor].
Jeong SY; Park WW; Kim YS; Park YI; Kim SH; Yoon WJ; Moon JS; Lee BM; Hong SW; Kang YK
Korean J Gastroenterol; 2014 Aug; 64(2):87-92. PubMed ID: 25168050
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic Gastrointestinal Stromal Tumor: Clinicopathologic Features and Prognosis.
Liu Z; Tian Y; Xu G; Liu S; Guo M; Lian X; Fan D; Zhang H; Feng F
J Clin Gastroenterol; 2017 Oct; 51(9):850-856. PubMed ID: 27673752
[TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China.
Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
Cancer Med; 2017 Dec; 6(12):2796-2803. PubMed ID: 29058376
[TBL] [Abstract][Full Text] [Related]
15. Retrospective study of the clinicopathological characteristics and prognostic factors of gastrointestinal stromal tumors in Chinese patients.
Hu X; Zhang Q; Wang Z; Ren H; Su P; Kou Y
Ann Diagn Pathol; 2022 Dec; 61():152050. PubMed ID: 36257237
[TBL] [Abstract][Full Text] [Related]
16. Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival.
Xu SJ; Zhang SY; Dong LY; Lin GS; Zhou YJ
BMC Cancer; 2021 Nov; 21(1):1170. PubMed ID: 34724907
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization.
Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V
J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables.
Unalp HR; Derici H; Kamer E; Bozdag AD; Tarcan E; Onal MA
Can J Surg; 2009 Feb; 52(1):31-8. PubMed ID: 19234649
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R
Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade.
Hasegawa T; Matsuno Y; Shimoda T; Hirohashi S
Hum Pathol; 2002 Jun; 33(6):669-76. PubMed ID: 12152168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
